Keyphrases
AIDS/HIV
100%
Hemodialysis
100%
Hepatitis B Vaccine
100%
Protective Antibodies
75%
Antibody Titer
62%
End-stage Renal Disease Patients
50%
Hemoglobin
37%
Hemodialysis Patients
37%
End-stage Renal Disease
25%
Response Rate
25%
Hepatitis B Surface Antigen (HBsAg)
25%
United States
12%
Immune Response
12%
North America
12%
Immunization
12%
Vaccination
12%
Recombinant
12%
High Risk
12%
Infection Risk
12%
Centers for Disease Control
12%
Disease Prevention
12%
Human Immunodeficiency Virus Infection
12%
Laboratory Data
12%
Logistic Regression Analysis
12%
Demographic Information
12%
Adult Humans
12%
Odds Ratio
12%
Retrospective Cohort Study
12%
Hepatitis B Virus
12%
Dialysis Facility
12%
Long-term Hemodialysis
12%
Third Dose
12%
State-based
12%
Hepatitis B Surface Antibody
12%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Hemodialysis
100%
Hepatitis B Vaccination
100%
Antibody Titer
62%
Hepatitis B Virus
50%
Hepatitis B Surface Antibody
37%
Vaccination
37%
Human Immunodeficiency Virus Infection
12%
Immune Response
12%
Titer
12%
Virus Vaccine
12%
Immunology
12%